Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fasting | 3 | 2020 | 276 | 0.800 |
Why?
|
| Energy Intake | 3 | 2020 | 499 | 0.730 |
Why?
|
| Geriatric Assessment | 1 | 2020 | 231 | 0.550 |
Why?
|
| Patient Compliance | 1 | 2020 | 585 | 0.460 |
Why?
|
| Phosphatidylinositol Phosphates | 3 | 2006 | 41 | 0.350 |
Why?
|
| Qc-SNARE Proteins | 1 | 2006 | 9 | 0.250 |
Why?
|
| Histidine | 1 | 2005 | 66 | 0.230 |
Why?
|
| Toxoplasmosis, Cerebral | 1 | 2004 | 2 | 0.210 |
Why?
|
| Sulfadiazine | 1 | 2004 | 6 | 0.210 |
Why?
|
| Mycobacterium Infections | 1 | 2004 | 61 | 0.210 |
Why?
|
| Catheters, Indwelling | 1 | 2004 | 96 | 0.210 |
Why?
|
| Ureteral Calculi | 1 | 2004 | 16 | 0.200 |
Why?
|
| Mycobacterium | 1 | 2004 | 116 | 0.190 |
Why?
|
| Mobility Limitation | 2 | 2020 | 66 | 0.190 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2004 | 130 | 0.190 |
Why?
|
| Catheterization, Central Venous | 1 | 2004 | 122 | 0.190 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2006 | 418 | 0.190 |
Why?
|
| Feeding Behavior | 2 | 2019 | 681 | 0.190 |
Why?
|
| Bacteremia | 1 | 2004 | 221 | 0.180 |
Why?
|
| Pilot Projects | 3 | 2020 | 1867 | 0.150 |
Why?
|
| Factor Analysis, Statistical | 1 | 2020 | 292 | 0.150 |
Why?
|
| Membrane Proteins | 1 | 2005 | 1165 | 0.140 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2017 | 51 | 0.130 |
Why?
|
| Synaptosomal-Associated Protein 25 | 2 | 2006 | 25 | 0.120 |
Why?
|
| Body Composition | 1 | 2020 | 704 | 0.120 |
Why?
|
| Interleukin-6 | 1 | 2020 | 780 | 0.120 |
Why?
|
| Age Factors | 2 | 2020 | 3313 | 0.110 |
Why?
|
| Self Report | 1 | 2020 | 863 | 0.110 |
Why?
|
| Vesicular Transport Proteins | 2 | 2006 | 86 | 0.110 |
Why?
|
| Eating | 1 | 2017 | 389 | 0.110 |
Why?
|
| Overweight | 1 | 2019 | 606 | 0.100 |
Why?
|
| Weight Loss | 1 | 2019 | 832 | 0.100 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2010 | 41 | 0.080 |
Why?
|
| Antibodies, Monoclonal | 1 | 2017 | 1519 | 0.080 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2010 | 154 | 0.070 |
Why?
|
| Enterotoxigenic Escherichia coli | 1 | 2008 | 5 | 0.070 |
Why?
|
| Enterotoxins | 1 | 2008 | 89 | 0.070 |
Why?
|
| Bacterial Toxins | 1 | 2008 | 108 | 0.070 |
Why?
|
| Escherichia coli Infections | 1 | 2008 | 129 | 0.070 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 8243 | 0.070 |
Why?
|
| Protein Structure, Tertiary | 2 | 2006 | 862 | 0.060 |
Why?
|
| Travel | 1 | 2008 | 136 | 0.060 |
Why?
|
| Diarrhea | 1 | 2008 | 192 | 0.060 |
Why?
|
| Surveys and Questionnaires | 1 | 2020 | 6021 | 0.060 |
Why?
|
| Micelles | 1 | 2006 | 40 | 0.060 |
Why?
|
| SNARE Proteins | 1 | 2006 | 40 | 0.060 |
Why?
|
| Static Electricity | 1 | 2006 | 113 | 0.060 |
Why?
|
| Interleukin-10 | 1 | 2008 | 309 | 0.060 |
Why?
|
| Valine | 1 | 2006 | 80 | 0.060 |
Why?
|
| Organothiophosphates | 1 | 2006 | 5 | 0.060 |
Why?
|
| Escherichia coli Proteins | 1 | 2008 | 206 | 0.060 |
Why?
|
| Leucine | 1 | 2006 | 116 | 0.060 |
Why?
|
| Cytoplasm | 1 | 2006 | 269 | 0.060 |
Why?
|
| Cloning, Molecular | 1 | 2006 | 539 | 0.060 |
Why?
|
| Aged | 3 | 2020 | 25850 | 0.060 |
Why?
|
| Tryptophan | 1 | 2006 | 180 | 0.060 |
Why?
|
| Amino Acid Motifs | 1 | 2005 | 224 | 0.060 |
Why?
|
| Green Fluorescent Proteins | 1 | 2006 | 405 | 0.050 |
Why?
|
| Cytosol | 1 | 2005 | 227 | 0.050 |
Why?
|
| Endosomes | 1 | 2005 | 140 | 0.050 |
Why?
|
| Humans | 11 | 2020 | 144261 | 0.050 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2005 | 561 | 0.050 |
Why?
|
| Protein Transport | 1 | 2005 | 441 | 0.050 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2006 | 629 | 0.050 |
Why?
|
| HeLa Cells | 1 | 2005 | 650 | 0.050 |
Why?
|
| Transfection | 1 | 2005 | 938 | 0.050 |
Why?
|
| ErbB Receptors | 1 | 2006 | 627 | 0.050 |
Why?
|
| Phosphoproteins | 1 | 2005 | 343 | 0.050 |
Why?
|
| Binding Sites | 1 | 2005 | 1327 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 1 | 2005 | 592 | 0.040 |
Why?
|
| Lipids | 1 | 2006 | 700 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 2005 | 2154 | 0.040 |
Why?
|
| Stroke | 1 | 2010 | 1254 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2008 | 2143 | 0.040 |
Why?
|
| Protein Binding | 1 | 2006 | 2270 | 0.040 |
Why?
|
| Male | 4 | 2020 | 72035 | 0.040 |
Why?
|
| Female | 4 | 2020 | 77976 | 0.040 |
Why?
|
| Antigen-Antibody Reactions | 1 | 2017 | 50 | 0.030 |
Why?
|
| Brain | 1 | 2010 | 2930 | 0.030 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2017 | 73 | 0.030 |
Why?
|
| Luminescent Measurements | 1 | 2017 | 76 | 0.030 |
Why?
|
| Muscle Strength | 1 | 2020 | 330 | 0.030 |
Why?
|
| Immunoassay | 1 | 2017 | 109 | 0.030 |
Why?
|
| Gait | 1 | 2019 | 313 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2019 | 706 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2019 | 1087 | 0.030 |
Why?
|
| Health Status | 1 | 2019 | 833 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2004 | 2730 | 0.020 |
Why?
|
| Inflammation | 1 | 2020 | 2877 | 0.020 |
Why?
|
| Adult | 3 | 2010 | 40262 | 0.020 |
Why?
|
| Time Factors | 1 | 2019 | 7155 | 0.020 |
Why?
|
| Mexico | 1 | 2008 | 233 | 0.020 |
Why?
|
| Quality of Life | 1 | 2019 | 3166 | 0.020 |
Why?
|
| Inositol | 1 | 2006 | 24 | 0.020 |
Why?
|
| Middle Aged | 2 | 2008 | 35762 | 0.020 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2006 | 56 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2010 | 1983 | 0.010 |
Why?
|
| Organophosphorus Compounds | 1 | 2006 | 84 | 0.010 |
Why?
|
| Molecular Structure | 1 | 2006 | 498 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2019 | 11643 | 0.010 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2006 | 346 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2006 | 1732 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2010 | 17009 | 0.010 |
Why?
|
| United States | 1 | 2008 | 15876 | 0.010 |
Why?
|